Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by firm, itchy nodules that develop on the skin, commonly on the arms, legs, and trunk. These nodules are often the result of a persistent itch-scratch cycle, where repeated scratching leads to further skin thickening and inflammation.
The condition is associated with dysregulation of the immune and nervous systems, making it complex and challenging to treat. Patients often experience severe, persistent itching that can interfere with sleep, daily activities, and overall well-being.
Standard treatments—including topical therapies, antihistamines, and systemic medications—may provide limited relief for some patients. As a result, clinical trials play a critical role in advancing more effective and targeted treatment options.
At Rejuvenation Dermatology, our prurigo nodularis clinical trials focus on evaluating innovative therapies that address both the neurological and inflammatory pathways driving the condition. Participants receive access to investigational treatments in a structured, medically supervised environment.
Each study follows strict ethical and regulatory standards, ensuring patient safety while contributing to the development of improved therapies. Our goal is to reduce itch intensity, promote skin healing, and break the chronic itch-scratch cycle to improve quality of life.
EVIDENCE DRIVES BETTER ITCH MANAGEMENT
We believe prurigo nodularis treatment should go beyond temporary symptom relief. Our clinical trials are designed to evaluate advanced therapies that target the underlying neurological and inflammatory pathways responsible for chronic itching and skin lesions.
RESEARCH INTEGRATED INTO REAL CLINICAL PRACTICE
All studies are conducted within active dermatology clinics, allowing patients to receive care in a familiar, professional setting. Our dermatologists understand the complexity of chronic itch conditions and approach treatment with precision and care.
ETHICS ARE NON-NEGOTIABLE
Every prurigo nodularis trial undergoes independent ethics board review prior to enrollment. Participants are fully informed, carefully screened, and continuously monitored, with safety protocols that meet and exceed regulatory standards.
STANDARDIZED, NATIONAL EXECUTION
Our multi-site research network operates under centralized oversight and standardized protocols, ensuring consistent execution, high-quality data collection, and reliable outcomes across all participating locations.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. Through participating in regulated clinical trials, the organization helps to shape development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
DERMATOLOGY-LED RESEARCH
Our PN trials are led by experienced dermatologists with expertise in chronic inflammatory and itch-related skin conditions. Physician oversight ensures every participant receives care that is both clinically sound and research-driven.
TARGETING THE ITCH-SCRATCH CYCLE
Prurigo nodularis is driven by a complex interaction between the nervous and immune systems. Our studies focus on therapies designed to interrupt this cycle and provide more effective, long-term relief.
SAFETY FIRST, ALWAYS
Patient safety is at the core of every study. Strict eligibility criteria, ongoing monitoring, and adherence to Good Clinical Practice guidelines ensure a safe and controlled research environment.
CONSISTENT EXECUTION, TRUSTED RESULTS
Sponsors rely on our ability to recruit efficiently and deliver high-quality, audit-ready data. This structured approach ensures a seamless and reliable experience for participants.
ADVANCING FUTURE TREATMENTS
Participation in clinical trials contributes to the development of new therapies that may significantly improve the management of prurigo nodularis and other chronic itch conditions.
Eligibility depends on the specific study but generally includes individuals with moderate to severe or persistent symptoms.
Prurigo nodularis is a chronic skin condition characterized by firm, itchy nodules caused by repeated scratching.
Participants may access new therapies while receiving expert dermatological care.
Yes, all treatments are carefully studied and monitored under strict medical and ethical guidelines.
PRURIGO NODULARIS CLINICAL TRIALS | CLINICAL TRIALS CANADA | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
